These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3493737)

  • 21. A survey of isolates of Klebsiella pneumoniae which cross-react with HLA-B27-associated cell-surface structure on the lymphocytes of patients with ankylosing spondylitis.
    Geczy AF; Yap J
    J Rheumatol; 1982; 9(1):97-100. PubMed ID: 7045364
    [No Abstract]   [Full Text] [Related]  

  • 22. Cytotoxic T lymphocytes against disease-associated determinant(s) in ankylosing spondylitis.
    Geczy AF; McGuigan LE; Sullivan JS; Edmonds JP
    J Exp Med; 1986 Sep; 164(3):932-7. PubMed ID: 3528379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical studies on a factor isolated from Klebsiella K43-BTS1 that cross-reacts with cells from HLA-B27 positive patients with ankylosing spondylitis.
    Upfold LI; Sullivan JS; Geczy AF
    Hum Immunol; 1986 Nov; 17(3):224-38. PubMed ID: 3539895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cross-tolerance hypothesis, HLA-B27 and ankylosing spondylitis.
    Ebringer A
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):53-66. PubMed ID: 6418259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of cross-reaction between HLA B27 and yersinia enterocolitica or chlamydia trachomatis in reactive arthritis and ankylosing spondylitis.
    Roudier J; De Montclos H; Thouvenot D; Chomel JJ; Guillermet FN; Betuel H
    Clin Rheumatol; 1985 Dec; 4(4):487. PubMed ID: 3879474
    [No Abstract]   [Full Text] [Related]  

  • 26. Further observations on Klebsiella molecular cross-reactivity in HLA-B27 positive persons.
    Trull AK; Panayi GS
    J Rheumatol; 1985 Oct; 12(5):1024. PubMed ID: 3910831
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular variants of the HLA-B27 antigen in healthy individuals and patients with spondylarthropathies.
    Turek PJ; Grumet FC; Engleman EG
    Immunol Rev; 1985 Aug; 86():71-91. PubMed ID: 2412952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-B27 associated cross-reactive marker on the cells of New Zealand patients with ankylosing spondylitis.
    McGuigan LE; Geczy AF; Prendergast JK; Edmonds JP; Hart HH; Bashir HV
    Ann Rheum Dis; 1986 Feb; 45(2):144-8. PubMed ID: 3484937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of HLA-B27 antigens on mononuclear leucocytes in ankylosing spondylitis.
    van der Gaag R; Luyendijk L; Linssen A; Kijlstra A
    Clin Exp Immunol; 1985 May; 60(2):311-5. PubMed ID: 3874023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ankylosing spondylarthritis, HLA B27 and the theory of crossed tolerance].
    Ebringer A
    Rev Rhum Mal Osteoartic; 1983 Nov; 50(11):763-9. PubMed ID: 6364315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-B27, ankylosing spondylitis and Klebsiella pneumoniae: toward a molecular approach.
    Toubert A; Philippon A; Amor B
    J Rheumatol; 1987 Apr; 14(2):391-3. PubMed ID: 3298651
    [No Abstract]   [Full Text] [Related]  

  • 32. HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis.
    Trull A; Ebringer A; Panayi G; Ebringer R; James DC
    Clin Exp Immunol; 1984 Jan; 55(1):74-80. PubMed ID: 6607143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further observations upon HLA-B27, Yersinia enterocolitica, and ankylosing spondylitis.
    Pease PE; Balmer SE; Tallack JE; Chahal H; Ibbotson J; Bartlett LR; Lane M; Allan RN
    Ann Rheum Dis; 1986 Jun; 45(6):526-8. PubMed ID: 3488038
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathogenesis of ankylosing spondylitis: the state of the art.
    Calin A
    Br J Rheumatol; 1988; 27 Suppl 2():106-9. PubMed ID: 3042068
    [No Abstract]   [Full Text] [Related]  

  • 35. Ankylosing spondylitis syndrome in patients without HLA-B27.
    Jajić I; Kerhin V; Kastelan A
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):136. PubMed ID: 6606465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathogenesis of ankylosing spondylitis: relation between HLA-B 27 and Klebsiella aerogenes].
    Giordano N; Fioravanti A; Calabria AA; Frati E; Castagna ML; Contu L; Menegale G; Marcolongo R
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1995-2001. PubMed ID: 6367774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enteric bacteria and HLA-B27 associated cell surface modification in patients with seronegative spondarthritis.
    Edmonds J; Geczy AF; Sullivan JS; Prendergast JK; Upfold LI; Bashir HV
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):75-82. PubMed ID: 6606476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-B27: speculations on the nature of its involvement in ankylosing spondylitis.
    Upfold LI; Sullivan JS; Prendergast JK; Geczy AF
    Prog Allergy; 1985; 36():177-89. PubMed ID: 3881781
    [No Abstract]   [Full Text] [Related]  

  • 39. Cross-reactivity of anti-Klebsiella K43 BTS 1 serum and lymphocytes of patients with ankylosing spondylitis: antipodean curiosity?
    Geczy AF; Prendergast JK; McGuigan LE; Upfold LI; Sullivan JS
    Lancet; 1985 May; 1(8438):1169. PubMed ID: 2860379
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoclonal antibody (B27M2) subdividing HLA-B27.
    Grumet FC; Fendly BM; Fish L; Foung S; Engleman EG
    Hum Immunol; 1982 Aug; 5(1):61-72. PubMed ID: 6981637
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.